FR
Contact
EquipeExpertise
ActualitésClassements & distinctionsPublications
À propos de nousCarrièreContact
de|fr|it|en
DEITEN
Contact
EquipeExpertise
ActualitésClassements & distinctionsPublications
À propos de nousCarrièreContact
de|fr|it|en
DEITEN
de|fr|it|en
Bâle Berne Binningen China Desk Genève Gstaad Japan Desk Lausanne Lugano Sion ZurichBâle Berne Binningen China Desk Genève Gstaad Japan Desk Lausanne Lugano Sion Zurich
  • Equipe
  • Expertise
  • Actualités
  • Classements & distinctions
  • Publications
  • À propos de nous
  • Carrière
  • Contact
  • LinkedIn
  • Instagram
Imprint–Terms of use–Privacy notice–Cookie policy–
© 2026
  • Equipe
  • Expertise
  • Actualités
  • Classements & distinctions
  • Publications
  • À propos de nous
  • Carrière
  • Contact
  • LinkedIn
  • Instagram
Imprint–Terms of use–Privacy notice–Cookie policy–
© 2026

Transactions & cas

Dr. Nicolas Mosimann
  • Kellerhals Carrard advises on the sale of a majority stake in Hipp Technology GroupKellerhals Carrard advises on the sale of a majority stake in Hipp Technology Group24 mars 2026
  • Kellerhals Carrard berät Eigentümer der Tretor AG bei Transaktion mit Pictet Alternative AdvisorsKellerhals Carrard berät Eigentümer der Tretor AG bei Transaktion mit Pictet Alternative Advisors11 mars 2026
  • Deal Ticker: Kellerhals Carrard advised on the sale of LakeraDeal Ticker: Kellerhals Carrard advised on the sale of Lakera6 novembre 2025
  • Deal Ticker: Kellerhals Carrard advised Sofinnova Partners and Earlybird Venture Capital on financing round with HAYA TherapeuticsDeal Ticker: Kellerhals Carrard advised Sofinnova Partners and Earlybird Venture Capital on financing round with HAYA Therapeutics15 mai 2025
  • Deal Ticker: Kellerhals Carrard Advised MoonLake Immunotherapeutics on Debt Financing with Hercules Capital, Inc.Deal Ticker: Kellerhals Carrard Advised MoonLake Immunotherapeutics on Debt Financing with Hercules Capital, Inc.4 avril 2025
  • Kellerhals Carrard Advises on the Sale of Baccinex S.A. to Adragos PharmaKellerhals Carrard Advises on the Sale of Baccinex S.A. to Adragos Pharma3 décembre 2024
  • Deal Ticker: Kellerhals Carrard Advised on Acquisition of Majority Stake in Walter Meier (Fertigungslösungen) AGDeal Ticker: Kellerhals Carrard Advised on Acquisition of Majority Stake in Walter Meier (Fertigungslösungen) AG27 mai 2024
  • Deal Ticker: Novartis hands over the Life-Science-Park Rhine Valley to GETEC Switzerland.Deal Ticker: Novartis hands over the Life-Science-Park Rhine Valley to GETEC Switzerland.23 août 2023
  • Deal Ticker: Kellerhals Carrard acted as lead counsel in connection with Biognosys’ strategic partnership with Bruker CorporationDeal Ticker: Kellerhals Carrard acted as lead counsel in connection with Biognosys’ strategic partnership with Bruker Corporation6 janvier 2023
  • Deal Ticker: Kellerhals Carrard advised BVF on the purchase agreement with NLS Pharmaceutics.Deal Ticker: Kellerhals Carrard advised BVF on the purchase agreement with NLS Pharmaceutics.19 décembre 2022
  • MoonLake Immunotherapeutics AG Announces Closing of Business Combination with Helix Acquisition Corp.6 avril 2022
  • Deal-Ticker: Swiss entrepreneurial group led by Kontivia acquires majority stake in Katadyn GroupDeal-Ticker: Swiss entrepreneurial group led by Kontivia acquires majority stake in Katadyn Group13 octobre 2021